About «Grindeks»

«Grindeks» is the leading pharmaceutical company in the Baltic states. Main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients.

«Grindeks» specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups.

«Grindeks» Group consists of 4 subsidiary companies in Latvia, Estonia and Russia, as well representatives and representative offices in 14 countries.

Products are exported to more than 40 countries, export comprises more than 96% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, Japan, USA.

«Grindeks» shares are listed in the Official List of "NASDAQ OMX Riga".